The Potential of the CNS as a Reservoir for HIV-1 Infection: Implications for HIV Eradication. (Q38419425)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25869939%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

review article

1 reference

title

The Potential of the CNS as a Reservoir for HIV-1 Infection: Implications for HIV Eradication (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25869939%20AND%20SRC:MED&resulttype=core&format=json

eradication of infectious diseases

5 March 2020

main subject

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25869939%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

author name string

Alessandro F Fois

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25869939%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

publication date

1 June 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25869939%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

published in

Current HIV/AIDS reports

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25869939%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25869939%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25869939%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

page(s)

299-303

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25869939%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11904-015-0257-9

5 March 2020

exact match

0 references

cites work

Survival of persons with and without HIV infection in Denmark, 1995-2005.

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0257-9

HIV rebounds from latently infected cells, rather than from continuing low-level replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0257-9

Recovery of replication-competent HIV despite prolonged suppression of plasma viremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0257-9

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0257-9

Redefining the viral reservoirs that prevent HIV-1 eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0257-9

Is the central nervous system a reservoir of HIV-1?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0257-9

Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0257-9

Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0257-9

Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0257-9

Absence of detectable HIV-1 viremia after treatment cessation in an infant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0257-9

Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0257-9

Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0257-9

RNA-based gene therapy for HIV with lentiviral vector-modified CD34(+) cells in patients undergoing transplantation for AIDS-related lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0257-9

Effects of atorvastatin and pravastatin on immune activation and T-cell function in antiretroviral therapy-suppressed HIV-1-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0257-9

Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0257-9

Is specific HIV eradication from the brain possible or needed?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0257-9

Pathogenesis of HIV in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0257-9

Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0257-9

Influence of HAART on HIV-related CNS disease and neuroinflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0257-9

The contribution of monocyte infection and trafficking to viral persistence, and maintenance of the viral reservoir in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0257-9

Astrocytes: biology and pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0257-9

Brain cell reservoirs of latent virus in presymptomatic HIV-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0257-9

Gamma interferon primes productive human immunodeficiency virus infection in astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0257-9

Extensive astrocyte infection is prominent in human immunodeficiency virus-associated dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0257-9

Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0257-9

In situ amplification and detection of HIV-1 DNA in fixed pediatric AIDS brain tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0257-9

Use of laser capture microdissection to detect integrated HIV-1 DNA in macrophages and astrocytes from autopsy brain tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0257-9

Molecular and pathologic insights from latent HIV-1 infection in the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0257-9

Neurovirological correlation with HIV-associated neurocognitive disorders and encephalitis in a HAART-era cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0257-9

The National NeuroAIDS Tissue Consortium brain gene array: two types of HIV-associated neurocognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0257-9

HIV-1 viral escape in cerebrospinal fluid of subjects on suppressive antiretroviral treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0257-9

Low levels of HIV-1 RNA detected in the cerebrospinal fluid after up to 10 years of suppressive therapy are associated with local immune activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0257-9

An example of genetically distinct HIV type 1 variants in cerebrospinal fluid and plasma during suppressive therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0257-9

A simian immunodeficiency virus-infected macaque model to study viral reservoirs that persist during highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0257-9

A simian immunodeficiency virus macaque model of highly active antiretroviral treatment: viral latency in the periphery and the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0257-9

Replication-competent simian immunodeficiency virus (SIV) Gag escape mutations archived in latent reservoirs during antiretroviral treatment of SIV-infected macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0257-9

HIV-1 entry and trans-infection of astrocytes involves CD81 vesicles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0257-9

The NRTIs lamivudine, stavudine and zidovudine have reduced HIV-1 inhibitory activity in astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0257-9

In vivo delivery of siRNA to the brain by carbosilane dendrimer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0257-9

Nanoemulsion-based intranasal drug delivery system of saquinavir mesylate for brain targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0257-9

Neuroprotective maraviroc monotherapy in simian immunodeficiency virus-infected macaques: reduced replicating and latent SIV in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0257-9

Detection and localisation of HIV-1 DNA and RNA in fixed adult AIDS brain by polymerase chain reaction/in situ hybridisation technique

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25869939

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11904-015-0257-9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25869939%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference